University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Jeffrey Golden, M.D.

Associate medical director of the Lung Transplantation Program

Dr. Jeffrey Golden, associate medical director of Lung Transplantation, is a pulmonologist who treats patients with severe lung disease, particularly candidates for lung transplants. In addition, he is director of clinical trials for the Interstitial Lung Disease Program. In 2010, one of Golden's longtime patients, Nina Ireland, left $48 million — almost her entire estate — to UCSF to create the Nina Ireland Lung Disease Program.

Golden earned a bachelor's degree at Yale University and a medical degree at Washington University in St. Louis in 1972. He completed internal medicine and pulmonary training at UCSF. He completed pulmonary research training at UCSF's Cardiovascular Research Institute where he studied ozone inhalation in humans as a model of asthma. He is a professor of clinical medicine at UCSF.

Clinics

Interstitial Lung Disease Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-2568

Hours: Friday
8 a.m. – noon

Lung Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Pulmonary Practice at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0359
Phone: (415) 353-2961
Fax: (415) 353-2568

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Jeffrey Golden

Education

Washington University School of Medicine 1972

Residencies

UCSF Medical Center, Internal Medicine 1975

Fellowships

UCSF Medical Center, Pulmonary Medicine 1977

Selected Research and Publications

  1. Louis DN, Gerber GK, Baron JM, Bry L, Dighe AS, Getz G, Higgins JM, Kuo FC, Lane WJ, Michaelson JS, Le LP, Mermel CH, Gilbertson JR, Golden JA. Computational pathology: an emerging definition. Arch Pathol Lab Med. 2014 Sep; 138(9):1133-8.
  2. Kern RM, Seethamraju H, Blanc PD, Sinha N, Loebe M, Golden J, Kukreja J, Scheinin S, Hays S, Kleinhenz ME, Leard L, Hoopes C, Singer JP. The Feasibility of Lung Transplantation in HIV-Seropositive Patients. Ann Am Thorac Soc. 2014 Jul; 11(6):882-9.
  3. Cho G, Lim Y, Cho IT, Simonet JC, Golden JA. Arx together with FoxA2, regulates Shh floor plate expression. Dev Biol. 2014 Sep 1; 393(1):137-48.
  4. Meilleur KG, Zukosky K, Medne L, Fequiere P, Powell-Hamilton N, Winder TL, Alsaman A, El-Hattab AW, Dastgir J, Hu Y, Donkervoort S, Golden JA, Eagle R, Finkel R, Scavina M, Hood IC, Rorke-Adams LB, Bönnemann CG. Clinical, Pathologic, and Mutational Spectrum of Dystroglycanopathy Caused by LARGE Mutations. J Neuropathol Exp Neurol. 2014 May; 73(5):425-41.
  5. Johannson KA, de Boer K, Wolters PJ, Golden JA, Lee JS, Collard HR. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT. Lancet Respir Med. 2014 May; 2(5):e5.
  6. Lysko DE, Putt M, Golden JA. SDF1 Reduces Interneuron Leading Process Branching through Dual Regulation of Actin and Microtubules. J Neurosci. 2014 Apr 2; 34(14):4941-62.
  7. Sunnen CN, Simonet JC, Marsh ED, Golden JA. Arx is required for specification of the zona incerta and reticular nucleus of the thalamus. J Neuropathol Exp Neurol. 2014 Mar; 73(3):253-61.
  8. Greenland JR, Jewell NP, Gottschall M, Trivedi NN, Kukreja J, Hays SR, Singer JP, Golden JA, Caughey GH. Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection. Am J Transplant. 2014 Apr; 14(4):831-40.
  9. Teissier N, Fallet-Bianco C, Delezoide AL, Laquerrière A, Marcorelles P, Khung-Savatovsky S, Nardelli J, Cipriani S, Csaba Z, Picone O, Golden JA, Van Den Abbeele T, Gressens P, Adle-Biassette H. Cytomegalovirus-induced brain malformations in fetuses. J Neuropathol Exp Neurol. 2014 Feb; 73(2):143-58.
  10. Singer JP, Blanc PD, Dean YM, Hays S, Leard L, Kukreja J, Golden J, Katz PP. Development and validation of a lung transplant-specific disability questionnaire. Thorax. 2014 May; 69(5):445-50.
  11. Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP. Outcomes in systemic sclerosis-related lung disease after lung transplantation. Transplantation. 2013 Apr 15; 95(7):975-80.
  12. Sayah DM, Schwartz BS, Kukreja J, Singer JP, Golden JA, Leard LE. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 2013 Apr; 15(2):E70-4.
  13. Sayah DM, Koff JL, Leard LE, Hays SR, Golden JA, Singer JP. Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant. 2013 Jan-Feb; 27(1):E64-71.
  14. Greenland JR, Jones KD, Hays SR, Golden JA, Urisman A, Jewell NP, Caughey GH, Trivedi NN. Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2013 Feb 15; 187(4):417-23.
  15. Yang YJ, Baltus AE, Mathew RS, Murphy EA, Evrony GD, Gonzalez DM, Wang EP, Marshall-Walker CA, Barry BJ, Murn J, Tatarakis A, Mahajan MA, Samuels HH, Shi Y, Golden JA, Mahajnah M, Shenhav R, Walsh CA. Microcephaly gene links trithorax and REST/NRSF to control neural stem cell proliferation and differentiation. Cell. 2012 Nov 21; 151(5):1097-112.
  16. Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB. Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol. 2012 Jul; 71(7):640-53.
  17. Moore KD, Chen R, Cilluffo M, Golden JA, Phelps PE. Lis1 reduction causes tangential migratory errors in mouse spinal cord. J Comp Neurol. 2012 Apr 15; 520(6):1198-211.
  18. Singer JP, Boker A, Metchnikoff C, Binstock M, Boettger R, Golden JA, Glidden DV, Arron ST. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients. J Heart Lung Transplant. 2012 Jul; 31(7):694-9.
  19. Cha SI, Chang CS, Kim EK, Lee JW, Matthay MA, Golden JA, Elicker BM, Jones K, Collard HR, Wolters PJ. Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis. Histopathology. 2012 Jul; 61(1):98-106.
  20. Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis. Transpl Infect Dis. 2012 Jun; 14(3):248-58.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.